Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Gestational Diabetes Management Guidelines

Initial Medical Nutrition Therapy

  • The American Diabetes Association (ADA) recommends that all pregnant individuals diagnosed with gestational diabetes begin medical nutrition therapy (MNT), self‑monitoring of blood glucose, and regular moderate‑intensity aerobic activity before any pharmacologic agents are introduced【1】.
  • MNT should be initiated at diagnosis with referral to a registered dietitian for a carbohydrate‑controlled meal plan delivering at least 175 g of carbohydrate per day, distributed across three meals and 2–4 snacks【2】.
  • For obese patients, a moderate caloric restriction of approximately 30 % can improve glycemic control without causing ketonemia, whereas hypocaloric diets that provoke ketonemia must be avoided【2】.
  • An evening snack is advised to prevent overnight ketosis, and carbohydrate intake at breakfast may need adjustment because it is often less well tolerated than later meals【2】.
  • At least 150 minutes per week of moderate‑intensity aerobic activity, spread over a minimum of three days, should be encouraged when not contraindicated【2】.

Glucose Monitoring and Targets

  • The ADA advises daily fasting and post‑prandial self‑monitoring of blood glucose to achieve strict targets【1】.
  • Target glucose values: fasting < 95 mg/dL (5.3 mmol/L); 1‑hour post‑prandial < 140 mg/dL (7.8 mmol/L); 2‑hour post‑prandial < 120 mg/dL (6.7 mmol/L)【1】.
  • Continuous glucose monitoring (CGM) may be used as an adjunct to help reach recommended A1C goals【1】.
  • A1C target: < 6 % (42 mmol/mol) if achievable without significant hypoglycemia; may be relaxed to < 7 % (53 mmol/mol) when necessary to avoid hypoglycemia【1】.

Pharmacologic Therapy When MNT Fails

  • If glucose targets are not met within 1–2 weeks of optimized MNT and activity, insulin is the first‑line pharmacologic treatment【3】.
  • All insulin formulations are considered safe for use during pregnancy and lactation【4】.
  • Glyburide (glibenclamide) shows minimal placental transfer (~4 %) and can be added when additional therapy is required, though its efficacy may be reduced in obese individuals or those with marked hyperglycemia【3】.
  • Metformin should not be used outside of clinical trials because it crosses the placenta and lacks sufficient safety data for routine use【3】.

Fetal and Maternal Surveillance

  • Fetal ultrasound for congenital anomalies is recommended when maternal A1C ≥ 7 % or fasting plasma glucose ≥ 120 mg/dL (6.7 mmol/L), as these levels are linked to higher risk of major malformations【3】.
  • Pregnant individuals should be instructed to monitor fetal movements during the final 8–10 weeks of gestation and report any perceived reduction promptly【3】.
  • Maternal blood pressure and urinary protein should be measured at every prenatal visit to detect preeclampsia, which occurs at increased rates in gestational diabetes【3】.
  • When antenatal corticosteroids are indicated for fetal lung maturity, they should not be withheld because of gestational diabetes; instead, glucose monitoring should be intensified and insulin doses temporarily increased as needed【3】.

Delivery Planning

  • For well‑controlled gestational diabetes, delivery is recommended between 38 and 40 weeks gestation in the absence of maternal or fetal compromise【3】.
  • No evidence supports delivery before 38 weeks without objective indications of compromise【3】.
  • Deliveries after 38 weeks are associated with a higher incidence of large‑for‑gestational‑age infants without a reduction in cesarean delivery rates【3】.
  • Intrapartum glucose management: maternal blood glucose should be monitored during labor, aiming for a range of 110–160 mg/dL to prevent fetal hypoxia and neonatal hypoglycemia【3】.

Postpartum Follow‑up

  • At 4–12 weeks postpartum, a 75‑g oral glucose tolerance test (OGTT) using non‑pregnancy diagnostic criteria should be performed; A1C is not recommended because pregnancy‑related hematologic changes can mask hyperglycemia【5】.
  • The OGTT is more sensitive than A1C for detecting both prediabetes and diabetes in the postpartum period【5】.
  • Diagnostic thresholds: fasting plasma glucose ≥ 126 mg/dL or 2‑hour plasma glucose ≥ 200 mg/dL confirm diabetes; if only one value is abnormal, repeat testing is required【5】.
  • Lifelong screening every 1–3 years (using OGTT, fasting glucose, or A1C) is advised because women with prior gestational diabetes have a 50–60 % lifetime risk of developing type 2 diabetes【5】.
  • Women identified with prediabetes should receive intensive lifestyle counseling and may be offered metformin to reduce progression to type 2 diabetes【5】.
  • Breastfeeding is recommended as it lowers the maternal risk of subsequent type 2 diabetes and should be supported【5】.

Contraception and Future Pregnancy Planning

  • Effective contraception, preferably long‑acting reversible methods, should be discussed and initiated immediately postpartum, especially if future pregnancy is planned before achieving glycemic targets【1】.
  • All individuals of reproductive potential with diabetes should have a preconception screening plan to identify and treat hyperglycemia before subsequent pregnancies, thereby reducing the risk of congenital anomalies【5】.

Common Pitfalls to Avoid

  • Do not perform a definitive diabetes test while the patient is still hospitalized postpartum, as this timing reduces sensitivity for detecting persistent glucose intolerance【5】.
  • Avoid using A1C for the 4–12 week postpartum screening because physiological changes of pregnancy can lead to false‑negative results【5】.
  • Do not delay the postpartum OGTT beyond 12 weeks, as many patients are lost to follow‑up and miss critical diabetes detection【5】.
  • Do not assume normal glucose tolerance without testing, since a substantial proportion of patients will have persistent diabetes or prediabetes after delivery【4】.

Management of Diabetes in Pregnancy

Preconception Care and Glycemic Targets

  • The American Diabetes Association recommends achieving A1C <6.5% (48 mmol/mol) before conception to minimize the risk of congenital anomalies, including anencephaly, microcephaly, congenital heart disease, and caudal regression 6, 7, 8, 9, 10
  • The American College of Obstetricians and Gynecologists suggests establishing multidisciplinary care with an endocrinologist, maternal-fetal medicine specialist, registered dietitian nutritionist, and diabetes care and education specialist when available 11, 12
  • Discontinue teratogenic medications immediately upon pregnancy planning or recognition, as they cause fetotoxicity, according to the American Diabetes Association 11, 12, 13, 9, 10
  • Obtain baseline testing, including A1C, creatinine, urinary albumin-to-creatinine ratio, thyroid-stimulating hormone, and comprehensive dilated eye examination, as recommended by the American Diabetes Association 11, 6, 12
  • Prescribe effective contraception and maintain use until glycemic targets are achieved, according to the American College of Obstetricians and Gynecologists 14, 11, 12, 8, 9
  • Prescribe prenatal vitamins with at least 400 mg of folic acid, as recommended by the American Diabetes Association 6

Glycemic Targets and Monitoring

  • The American Diabetes Association recommends fasting plasma glucose <95 mg/dL (5.3 mmol/L) and 1-hour postprandial <140 mg/dL (7.8 mmol/L) 11, 12, 13, 9
  • The American College of Endocrinology suggests an ideal target A1C <6% (42 mmol/mol) if achievable without significant hypoglycemia, and an acceptable target A1C <7% (53 mmol/mol) if necessary to prevent hypoglycemia 14, 11, 12, 8, 10, 9
  • Implement fasting and postprandial self-monitoring of blood glucose in both gestational diabetes and preexisting diabetes, as recommended by the American Diabetes Association 14, 11, 6, 12, 8
  • Continuous glucose monitoring (CGM) can be used as an adjunct to self-monitoring and helps achieve A1C targets, reducing macrosomia and neonatal hypoglycemia in type 1 diabetes, according to the American Diabetes Association 11, 12

Medical Nutrition Therapy and Lifestyle Management

  • The Academy of Nutrition and Dietetics recommends beginning with medical nutrition therapy, physical activity, and weight management before initiating pharmacologic therapy 13
  • The American Diabetes Association suggests a minimum daily intake of 175g carbohydrate, 71g protein, and 28g fiber, and consistent carbohydrate intake to match insulin dosing and avoid glucose fluctuations 13, 14, 8, 9
  • Referral to a registered dietitian is recommended to establish a food plan, insulin-to-carbohydrate ratio, and weight gain goals, according to the American Diabetes Association 14, 8

Insulin Management Protocol

  • The American Diabetes Association recommends using multiple daily injections with basal-bolus regimen or insulin pump technology 13
  • Insulin requirements increase exponentially during pregnancy, with a doubling of requirements by the third trimester, according to the American Diabetes Association 13
  • Type 2 diabetes often requires much higher insulin doses than type 1 diabetes, sometimes necessitating concentrated insulin formulations, as recommended by the American Diabetes Association 10

Essential Adjunctive Therapies

  • The American College of Obstetricians and Gynecologists recommends prescribing low-dose aspirin 100-150 mg daily starting at 12-16 weeks gestation to reduce preeclampsia risk 13, 9, 10
  • Target blood pressure: 110-135/85 mmHg to reduce risk of accelerated maternal hypertension while minimizing impaired fetal growth, according to the American College of Obstetricians and Gynecologists 9
  • Never use ACE inhibitors or ARBs during pregnancy due to fetotoxicity, as recommended by the American Diabetes Association 13, 9

Retinopathy Monitoring and Postpartum Management

  • The American Academy of Ophthalmology recommends dilated eye examinations ideally before pregnancy or in the first trimester, then every trimester and for 1 year postpartum as indicated by retinopathy degree 14, 8, 9, 10
  • Reduce insulin to 50% of end-pregnancy doses or 80% of pre-pregnancy doses immediately after delivery and monitor closely for hypoglycemia, especially during breastfeeding, as recommended by the American Diabetes Association 13
  • Test for persistent diabetes or prediabetes at 4-12 weeks postpartum with a 75-g oral glucose tolerance test using nonpregnancy criteria, according to the American Diabetes Association 9

REFERENCES

9

Management of Diabetes and Hypertension in Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

10

Overt Diabetes and Pregestational Type 2 Diabetes in Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

13

Management of Type 2 Diabetes in Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025